Literature DB >> 32929227

Comparative effectiveness of rituximab in multiple sclerosis.

Tomas Kalincik1,2, Maria Pia Sormani3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32929227     DOI: 10.1038/s41582-020-00412-5

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Delay from treatment start to full effect of immunotherapies for multiple sclerosis.

Authors:  Izanne Roos; Emmanuelle Leray; Federico Frascoli; Romain Casey; J William L Brown; Dana Horakova; Eva K Havrdova; Maria Trojano; Francesco Patti; Guillermo Izquierdo; Sara Eichau; Marco Onofrj; Alessandra Lugaresi; Alexandre Prat; Marc Girard; Pierre Grammond; Patrizia Sola; Diana Ferraro; Serkan Ozakbas; Roberto Bergamaschi; Maria José Sá; Elisabetta Cartechini; Cavit Boz; Franco Granella; Raymond Hupperts; Murat Terzi; Jeannette Lechner-Scott; Daniele Spitaleri; Vincent Van Pesch; Aysun Soysal; Javier Olascoaga; Julie Prevost; Eduardo Aguera-Morales; Mark Slee; Tunde Csepany; Recai Turkoglu; Youssef Sidhom; Riadh Gouider; Bart Van Wijmeersch; Pamela McCombe; Richard Macdonell; Alasdair Coles; Charles B Malpas; Helmut Butzkueven; Sandra Vukusic; Tomas Kalincik
Journal:  Brain       Date:  2020-09-01       Impact factor: 13.501

2.  Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.

Authors:  Andrew E Arrant; Skylar E Davis; Rachael M Vollmer; Charles F Murchison; James A Mobley; Alissa L Nana; Salvatore Spina; Lea T Grinberg; Anna M Karydas; Bruce L Miller; William W Seeley; Erik D Roberson
Journal:  Ann Clin Transl Neurol       Date:  2020-11-16       Impact factor: 5.430

  2 in total
  1 in total

Review 1.  Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics.

Authors:  Laura Cacciaguerra; Paola Tortorella; Maria A Rocca; Massimo Filippi
Journal:  Neurotherapeutics       Date:  2021-04-28       Impact factor: 6.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.